Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer.

Haura EB, Müller A, Breitwieser FP, Li J, Grebien F, Colinge J, Bennett KL.

J Proteome Res. 2011 Jan 7;10(1):182-90. doi: 10.1021/pr100863f. Epub 2010 Nov 9.

2.

Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors.

Minakata K, Takahashi F, Nara T, Hashimoto M, Tajima K, Murakami A, Nurwidya F, Yae S, Koizumi F, Moriyama H, Seyama K, Nishio K, Takahashi K.

Cancer Sci. 2012 Nov;103(11):1946-54. doi: 10.1111/j.1349-7006.2012.02408.x. Epub 2012 Sep 14.

3.

Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays.

Savitski MM, Fischer F, Mathieson T, Sweetman G, Lang M, Bantscheff M.

J Am Soc Mass Spectrom. 2010 Oct;21(10):1668-79. doi: 10.1016/j.jasms.2010.01.012. Epub 2010 Jan 25.

4.

Sequential peptide affinity purification system for the systematic isolation and identification of protein complexes from Escherichia coli.

Babu M, Butland G, Pogoutse O, Li J, Greenblatt JF, Emili A.

Methods Mol Biol. 2009;564:373-400. doi: 10.1007/978-1-60761-157-8_22.

PMID:
19544035
5.

Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.

Yamada T, Takeuchi S, Fujita N, Nakamura A, Wang W, Li Q, Oda M, Mitsudomi T, Yatabe Y, Sekido Y, Yoshida J, Higashiyama M, Noguchi M, Uehara H, Nishioka Y, Sone S, Yano S.

Oncogene. 2013 Sep 12;32(37):4427-35. doi: 10.1038/onc.2012.446. Epub 2012 Oct 8.

PMID:
23045273
6.
7.

Determination of the protein expression profiles of breast cancer cell lines by quantitative proteomics using iTRAQ labelling and tandem mass spectrometry.

Calderón-González KG, Valero Rustarazo ML, Labra-Barrios ML, Bazán-Méndez CI, Tavera-Tapia A, Herrera-Aguirre ME, Sánchez del Pino MM, Gallegos-Pérez JL, González-Márquez H, Hernández-Hernández JM, León-Ávila G, Rodríguez-Cuevas S, Guisa-Hohenstein F, Luna-Arias JP.

J Proteomics. 2015 Jun 21;124:50-78. doi: 10.1016/j.jprot.2015.04.018. Epub 2015 Apr 24. Erratum in: J Proteomics. 2015 Aug 3;126:312.

PMID:
25918110
8.

Effect of iTRAQ labeling on the relative abundance of peptide fragment ions produced by MALDI-MS/MS.

Gandhi T, Puri P, Fusetti F, Breitling R, Poolman B, Permentier HP.

J Proteome Res. 2012 Aug 3;11(8):4044-51. doi: 10.1021/pr300083x. Epub 2012 Jul 20.

PMID:
22770492
9.

Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays.

Smith MA, Hall R, Fisher K, Haake SM, Khalil F, Schabath MB, Vuaroqueaux V, Fiebig HH, Altiok S, Chen YA, Haura EB.

Sci Signal. 2015 Jan 13;8(359):ra4. doi: 10.1126/scisignal.2005906.

10.

A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling.

Blagoev B, Kratchmarova I, Ong SE, Nielsen M, Foster LJ, Mann M.

Nat Biotechnol. 2003 Mar;21(3):315-8. Epub 2003 Feb 10.

PMID:
12577067
11.

EGFR S1166 phosphorylation induced by a combination of EGF and gefitinib has a potentially negative impact on lung cancer cell growth.

Assiddiq BF, Tan KY, Toy W, Chan SP, Chong PK, Lim YP.

J Proteome Res. 2012 Aug 3;11(8):4110-9. doi: 10.1021/pr3002029. Epub 2012 Jul 10.

PMID:
22703031
12.

Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.

VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, Petricoin EF 3rd, Liotta LA, Espina V.

Mol Cell Proteomics. 2008 Oct;7(10):1902-24. doi: 10.1074/mcp.M800204-MCP200. Epub 2008 Aug 6.

13.

Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells.

Liu YC, Yen HY, Chen CY, Chen CH, Cheng PF, Juan YH, Chen CH, Khoo KH, Yu CJ, Yang PC, Hsu TL, Wong CH.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11332-7. doi: 10.1073/pnas.1107385108. Epub 2011 Jun 27.

14.

Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.

Furugaki K, Fukumura J, Iwai T, Yorozu K, Kurasawa M, Yanagisawa M, Moriya Y, Yamamoto K, Suda K, Mizuuchi H, Mitsudomi T, Harada N.

Int J Cancer. 2016 Feb 15;138(4):1024-32. doi: 10.1002/ijc.29848. Epub 2015 Oct 13.

15.

Shotgun proteome analysis utilising mixed mode (reversed phase-anion exchange chromatography) in conjunction with reversed phase liquid chromatography mass spectrometry analysis.

Phillips HL, Williamson JC, van Elburg KA, Snijders AP, Wright PC, Dickman MJ.

Proteomics. 2010 Aug;10(16):2950-60. doi: 10.1002/pmic.200900669.

PMID:
20662100
17.

Integration of high accuracy N-terminus identification in peptide sequencing and comparative protein analysis via isothiocyanate-based isotope labeling reagent with ESI ion-trap TOF MS.

Leng J, Wang H, Zhang L, Zhang J, Wang H, Cai T, Yao J, Guo Y.

J Am Soc Mass Spectrom. 2011 Jul;22(7):1204-13. doi: 10.1007/s13361-011-0129-5. Epub 2011 Apr 15.

PMID:
21953103
18.

Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.

Akca H, Tani M, Hishida T, Matsumoto S, Yokota J.

Lung Cancer. 2006 Oct;54(1):25-33. Epub 2006 Jul 26.

PMID:
16872715
19.

Short-course treatment with gefitinib enhances curative potential of radiation therapy in a mouse model of human non-small cell lung cancer.

Bokobza SM, Jiang Y, Weber AM, Devery AM, Ryan AJ.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):947-54. doi: 10.1016/j.ijrobp.2013.12.038.

PMID:
24606853
20.

[Relationship between EGFR Promoter Region Methylation and Secondary Resistance Which may be Induced by Gefitinib].

Wang Q, Li M, Hu C.

Zhongguo Fei Ai Za Zhi. 2015 Apr;18(4):193-8. doi: 10.3779/j.issn.1009-3419.2015.04.04. Chinese.

Supplemental Content

Support Center